|
G |
Mmp13 |
matrix metallopeptidase 13 |
decreases activity |
ISO |
prinomastat results in decreased activity of MMP13 protein |
CTD |
PMID:17267227 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases activity |
ISO |
prinomastat results in decreased activity of MMP2 protein |
CTD |
PMID:17267227 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
decreases activity |
ISO |
prinomastat results in decreased activity of MMP3 protein |
CTD |
PMID:17267227 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp8 |
matrix metallopeptidase 8 |
decreases activity |
ISO |
prinomastat results in decreased activity of MMP8 protein |
CTD |
PMID:17267227 |
|
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
prinomastat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|